166 related articles for article (PubMed ID: 11804070)
21. Acute graft-versus-host disease in pancreas transplantation: a comparison of two case presentations and a review of the literature.
Weinstein A; Dexter D; KuKuruga DL; Philosophe B; Hess J; Klassen D
Transplantation; 2006 Jul; 82(1):127-31. PubMed ID: 16861952
[TBL] [Abstract][Full Text] [Related]
22. Esophageal graft versus host disease.
Sodhi SS; Srinivasan R; Thomas RM
Gastrointest Endosc; 2000 Aug; 52(2):235. PubMed ID: 10922099
[No Abstract] [Full Text] [Related]
23. Activated circulating dendritic cells after hematopoietic stem cell transplantation predict acute graft-versus-host disease.
Lau J; Sartor M; Bradstock KF; Vuckovic S; Munster DJ; Hart DN
Transplantation; 2007 Apr; 83(7):839-46. PubMed ID: 17460553
[TBL] [Abstract][Full Text] [Related]
24. Post transplant persistence of host cells augments the intensity of acute graft-versus-host disease and level of donor chimerism, an explanation for graft-versus-host disease and rapid displacement of host cells seen following non-myeloablative stem cell transplantation?
Hirshfeld E; Weiss L; Kasir J; Zeira M; Slavin S; Shapira MY
Bone Marrow Transplant; 2006 Sep; 38(5):359-64. PubMed ID: 16862165
[TBL] [Abstract][Full Text] [Related]
25. Life-threatening graft-vs-host disease.
Vargas-Díez E; García-Díez A; Marín A; Fernández-Herrera J
Clin Dermatol; 2005; 23(3):285-300. PubMed ID: 15896544
[TBL] [Abstract][Full Text] [Related]
26. Antithymocyte globulin for the prevention of graft-versus-host disease after unrelated hematopoietic stem cell transplantation for acute myeloid leukemia: results from the multicenter German cooperative study group.
Basara N; Baurmann H; Kolbe K; Yaman A; Labopin M; Burchardt A; Huber C; Fauser AA; Schwerdtfeger R
Bone Marrow Transplant; 2005 May; 35(10):1011-8. PubMed ID: 15821768
[TBL] [Abstract][Full Text] [Related]
27. Successful immunotherapy in early relapse of acute myeloid leukemia after nonmyeloablative allogeneic stem cell transplantation.
Prinz E; Keil F; Kalhs P; Mitterbauer M; Rabitsch W; Rosenmayr A; Moser K; Schulenburg A; Lechner K; Greinix HT
Ann Hematol; 2003 May; 82(5):295-8. PubMed ID: 12679886
[TBL] [Abstract][Full Text] [Related]
28. Late appearance of acute graft-vs-host disease after suspending or tapering immunosuppressive drugs.
Valks R; Fernández-Herrera J; Bartolomé B; Fraga J; Daudén E; Garcia-Diéz A
Arch Dermatol; 2001 Jan; 137(1):61-5. PubMed ID: 11176662
[TBL] [Abstract][Full Text] [Related]
29. Graft-versus-host disease is associated with a lower relapse incidence after hematopoietic stem cell transplantation in patients with acute lymphoblastic leukemia.
Nordlander A; Mattsson J; Ringdén O; Leblanc K; Gustafsson B; Ljungman P; Svenberg P; Svennilson J; Remberger M
Biol Blood Marrow Transplant; 2004 Mar; 10(3):195-203. PubMed ID: 14993885
[TBL] [Abstract][Full Text] [Related]
30. Graft-versus-host disease of the kidney after rapid tapering of cyclosporin following reduced intensity hematopoietic stem cell transplantation.
Homma CI; Kami M; Masuo S; Sakiyama M; Kojima R; Hori A; Kusumi E; Katori H; Takeuchi K; Kishi Y; Murashige N; Kim SW; Takaue Y; Mitamura T
Bone Marrow Transplant; 2005 May; 35(9):929-30. PubMed ID: 15765112
[No Abstract] [Full Text] [Related]
31. Prognostic factors identifiable at the time of onset of acute graft-versus-host disease after allogeneic hematopoietic cell transplantation.
Lee KH; Choi SJ; Lee JH; Lee JS; Kim WK; Lee KB; Sohn SK; Kim JG; Kim DH; Seol M; Lee YS; Lee JH
Haematologica; 2005 Jul; 90(7):939-48. PubMed ID: 15996932
[TBL] [Abstract][Full Text] [Related]
32. Acquired ichthyosis as a manifestation of acute cutaneous graft-versus-host disease.
Huang J; Pol-Rodriguez M; Silvers D; Garzon MC
Pediatr Dermatol; 2007; 24(1):49-52. PubMed ID: 17300650
[TBL] [Abstract][Full Text] [Related]
33. [Hypercholesterolemia as a part of chronic GVHD after allogeneic stem cell transplantation].
Koyama M; Matsuoka K; Kunisaki Y; Takeuchi M; Matsue K
Rinsho Ketsueki; 2004 Oct; 45(10):1115-8. PubMed ID: 15553047
[TBL] [Abstract][Full Text] [Related]
34. Severe intestinal graft versus host disease after donor lymphocyte infusion; response to extracorporeal photochemotherapy.
Vural F; Donmez A; Doganavşargil B; Cagýrgan S; Alper H; Tombuloglu M
Transfus Apher Sci; 2005 Oct; 33(2):129-33. PubMed ID: 16150645
[TBL] [Abstract][Full Text] [Related]
35. Early (day -7) versus conventional (day -1) inception of cyclosporine-A for graft-versus-host disease prophylaxis after unrelated donor hematopoietic stem cell transplantation in children. Long-term results of an AIEOP prospective, randomized study.
Lanino E; Rondelli R; Locatelli F; Messina C; Pession A; Balduzzi A; Favre C; Santarone S; Rabusin M; Pollichieni S; Cesaro S; Dini G;
Biol Blood Marrow Transplant; 2009 Jun; 15(6):741-8. PubMed ID: 19450759
[TBL] [Abstract][Full Text] [Related]
36. Tacrolimus as monotherapy or combined with minidose methotrexate for graft-versus-host disease prophylaxis after allogeneic peripheral blood stem cell transplantation: long-term outcomes.
Uberti JP; Ayash L; Braun T; Reynolds C; Silver S; Ratanatharathorn V
Bone Marrow Transplant; 2004 Sep; 34(5):425-31. PubMed ID: 15273705
[TBL] [Abstract][Full Text] [Related]
37. Crypt loss is a marker of clinical severity of acute gastrointestinal graft-versus-host disease.
Melson J; Jakate S; Fung H; Arai S; Keshavarzian A
Am J Hematol; 2007 Oct; 82(10):881-6. PubMed ID: 17570511
[TBL] [Abstract][Full Text] [Related]
38. Cardiac manifestations of graft-versus-host disease.
Rackley C; Schultz KR; Goldman FD; Chan KW; Serrano A; Hulse JE; Gilman AL
Biol Blood Marrow Transplant; 2005 Oct; 11(10):773-80. PubMed ID: 16182178
[TBL] [Abstract][Full Text] [Related]
39. One-year cyclosporine prophylaxis reduces the risk of developing extensive chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantation.
Mengarelli A; Iori AP; Romano A; Cerretti R; Cerilli L; De Propris MS; Fenu S; Moleti ML; De Felice L; Girelli G; Arcese W
Haematologica; 2003 Mar; 88(3):315-23. PubMed ID: 12651271
[TBL] [Abstract][Full Text] [Related]
40. Chronic graft-versus-host disease manifesting as polymyositis: an uncommon presentation.
Couriel DR; Beguelin GZ; Giralt S; De Lima M; Hosing C; Kharfan-Dabaja MA; Anagnostopoulos A; Champlin R
Bone Marrow Transplant; 2002 Oct; 30(8):543-6. PubMed ID: 12379897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]